Science and Technology Committee
Evidence Check 2: Homeopathy
In preparation for the establishment of the Science and Technology Committee on 1 October, the former IUSS Committee commissioned work to assess the Government's use of evidence in policy-making. The Committee wrote to the Government on a number of topics and asked two questions: (1) What is the policy? (2) On what evidence is the policy based? The Government has now replied and having considered the responses the Committee has selected Homeopathy for its second Evidence Check. (The Government's response will be made available soon.)
Terms of Reference
The Committee invites short submissions by Friday 6 November on the following issues:
- Government policy on licensing of homeopathic products
- Government policy on the funding of homeopathy through the NHS
- the evidence base on homeopathic products and services.
Oral evidence
Previous sessions:
Monday 30 November 2009
Mr Mike O'Brien QC MP, Minister for Health Services, Department of Health;
Professor David Harper CBE, Director General, Health Improvement and Protection, and Chief Scientist, Department of Health;
Professor Kent Woods, Chief Executive, Medicines and Healthcare Products Regulatory Agency
Wednesday 25 November 2009
Professor Jayne Lawrence, Chief Scientific Adviser, Royal Pharmaceutical Society of Great Britain;
Robert Wilson, Chairman, British Association of Homeopathic Manufacturers;
Paul Bennett, Professional Standards Director, Boots;
Tracey Brown, Managing Director, Sense About Science;
Dr Ben Goldacre, Journalist.
Dr Peter Fisher, Director of Research, Royal London Homeopathic Hospital;
Professor Edzard Ernst, Director, Complementary Medicine Group, Peninsula Medical School;
Dr James Thallon, Medical Director, NHS West Kent;
Dr Robert Mathie, Research Development Adviser, British Homeopathic Association.
Written evidence
Press notices
20/10/09 Inquiry announced
